The federal government has aggressively intensified its scrutiny of health care fraud, placing substance abuse treatment centers and addiction recovery facilities directly in the crosshairs of federal law enforcement.

Through the False Claims Act (FCA) (31 U.S.C. §§ 3729–3733), federal prosecutors and whistleblowers target behavioral health providers who submit false, fraudulent, or medically unnecessary billing to government healthcare programs like Medicare, Medicaid, and TRICARE.

Driven by high demand for treatment services and substantial government reimbursement rates, addiction treatment facilities are facing unprecedented levels of civil investigative demands (CIDs), subpoenas, and enforcement actions from the Department of Justice (DOJ) and the Department of Health and Human Services Office of Inspector General (HHS-OIG).

What Is the Federal False Claims Act?

The Federal False Claims Act is a federal statute that imposes civil liability on individuals and companies that knowingly submit, or cause others to submit, false or fraudulent claims for payment to the federal government.

“Any person who knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval... is liable to the United States Government for a civil penalty... plus 3 times the amount of damages which the Government sustains because of the act of that person.” — 31 U.S.C. § 3729(a)(1)

Under the FCA, a provider can be held liable not only for intentional fraud, but also for acting with deliberate ignorance or reckless disregard regarding the truth or falsity of the claims submitted to government healthcare programs.

Why Are Addiction Treatment Facilities Facing High Enforcement Scrutiny?

Substance use disorder (SUD) facilities operate within a unique intersection of high patient vulnerability, complex billing codes, and substantial federal funding. Federal regulators focus heavily on addiction centers due to several recurring industry vulnerabilities:

1. Excessive and Medically Unnecessary Urine Drug Testing (UDT)

One of the most common triggers for FCA investigations involves automated or standing orders for high-complexity quantitative drug screens. Facilities that perform daily or weekly quantitative lab panels for every patient—regardless of clinical necessity—risk federal enforcement for billing medically unnecessary diagnostic services.

2. Patient Brokering and Anti-Kickback Violations

The FCA penalizes claims resulting from violations of the Anti-Kickback Statute (AKS) and the Eliminating Kickbacks in Recovery Act (EKRA). Substance abuse centers that pay marketers, sober homes, or call centers per-patient referral fees or financial commissions generate tainted claims under federal law.

3. Upcoding and "Pass-Through" Billing

Substance abuse facilities often utilize various levels of care, ranging from Outpatient (OP) to Intensive Outpatient (IOP) and Partial Hospitalization Programs (PHP). Facilities commit upcoding fraud when they bill for higher, more expensive levels of care than the patient actually received or clinically required.

4. Billing for Services Provided by Unqualified Staff

Federal funding rules require properly licensed professionals to render therapy sessions, medical assessments, and clinical counseling. Submitting reimbursement claims for group therapy or individual counseling led by unlicensed or credential-lacking staff constitutes false billing under the FCA.

Key Risk Areas and Common Billing Practices Under Investigation

How Do Whistleblower (Qui Tam) Lawsuits Trigger Federal Investigations?

A significant portion of False Claims Act investigations targeting substance abuse centers stem from Qui Tam whistleblower lawsuits. Under 31 U.S.C. § 3730, private citizens—often former employees, billing specialists, nurses, or clinicians—can file a confidential lawsuit under seal on behalf of the federal government.

• Financial Incentives: Whistleblowers (known as "relators") are legally entitled to receive 15% to 30% of the total financial recovery recovered by the government.

• Government Intervention: The Department of Justice evaluates the sealed lawsuit, issues subpoenas and CIDs, and decides whether to intervene in the prosecution.

What Are the Penalties for False Claims Act Violations?

Substance abuse centers found liable under the FCA face severe financial and administrative consequences:

• Treble Damages: Liability includes three times the actual financial loss sustained by Medicare, Medicaid, or other federal programs.

• Mandatory Statutory Fines: Per-claim statutory civil penalties assessed for every single false billing submission.

• Program Exclusion: Mandatory or permissive exclusion from participation in Medicare, Medicaid, and all federal healthcare programs imposed by the HHS-OIG.

• Corporate Integrity Agreements (CIAs): Multi-year government-monitored compliance and reporting mandates imposed on surviving facilities.

What Defense Strategies Protect Substance Abuse Facilities During Investigations?

When a substance abuse treatment facility faces a federal False Claims Act (FCA) investigation, Civil Investigative Demand (CID), or healthcare audit, establishing a strong defense requires immediate, proactive legal measures:

• Establishing Medical Necessity and Clinical Judgment: Defense teams use independent medical experts and contemporaneous clinical charts to show that level-of-care decisions, therapy sessions, and toxicological drug screens were tailored to the patient's diagnosis rather than driven by financial motives.

• Proving Lack of "Knowing" Intent (No Scienter): Under 31 U.S.C. § 3729, the government must prove actual knowledge, deliberate ignorance, or reckless disregard. Showing that billing irregularities resulted from honest administrative mistakes, software glitches, or reasonable reliance on ambiguous payer guidelines directly defeats the mental state requirement for FCA liability.

• Demonstrating Materiality (The Escobar Defense): Under federal precedent, an alleged regulatory non-compliance must be material to the government's actual payment decision. If Medicare, Medicaid, or TRICARE routinely pays claims despite full awareness of the technical billing deviation in question, the alleged violation lacks statutory materiality under the FCA.

• Leveraging Safe Harbors and Statutory Exceptions: For cases involving marketing or referral compensation under the Anti-Kickback Statute (AKS) or EKRA, counsel can establish that financial arrangements fit squarely within statutory safe harbors—such as bona fide employee W-2 compensation or commercial fair-market-value service contracts.

• Demonstrating an Active Corporate Compliance Program: Maintaining an active, effective compliance program—featuring ongoing internal audits, staff coding training, confidential internal hotlines, and prompt voluntary repayment of identified overpayments—rebuts claims of systemic fraud and mitigates severe administrative penalties.

• Invoking Advice of Counsel: Proving that the treatment facility consulted qualified healthcare regulatory attorneys and structured its billing policies or marketing arrangements in good-faith reliance on that legal advice provides a complete defense against "knowing" statutory violations.

What Are Related Federal Crimes and Statutes?

Understanding related federal statutes matters because federal prosecutors frequently stack criminal healthcare charges alongside civil False Claims Act allegations during parallel civil-criminal investigations.

• The Anti-Kickback Statute (AKS) (42 U.S.C. § 1320a-7b): This law matters because any healthcare claim resulting from an illegal referral fee, kickback, or patient inducement automatically constitutes a false claim under the FCA, exposing providers to severe criminal penalties of up to 10 years in federal prison per violation.

• The Eliminating Kickbacks in Recovery Act (EKRA) (18 U.S.C. § 220): This statute matters because it specifically criminalizes paying or receiving kickbacks or referral fees in the addiction recovery space regardless of whether claims are submitted to federal healthcare programs or private commercial insurance carriers.

• Federal Healthcare Fraud (18 U.S.C. § 1347): This crime matters because knowingly executing or attempting to execute a scheme to defraud any healthcare benefit program carries criminal sentences of up to 10 years in prison—or up to 20 years if the violation results in serious bodily injury.

• The Stark Law / Physician Self-Referral Law (42 U.S.C. § 1395nn): This civil statute matters because referring patients for designated health services to entities where a physician or immediate family member holds a financial interest creates immediate FCA civil liability and mandatory refund obligations.

• Mail Fraud and Wire Fraud (18 U.S.C. §§ 1341, 1343): These statutes matter because prosecutors routinely add wire and mail fraud counts to healthcare indictments based on electronic claim transmissions or mailed reimbursement checks, with each count carrying up to 20 years in federal prison.

Frequently Asked Questions (FAQs)

What is the difference between EKRA and the Anti-Kickback Statute for addiction facilities?

The Anti-Kickback Statute (AKS) applies specifically to healthcare referrals involving federal healthcare programs like Medicare and Medicaid. The Eliminating Kickbacks in Recovery Act (EKRA) is a broader statute that applies criminal penalties to kickbacks and referral fees in the addiction recovery space regardless of whether the payer is public or private insurance.

Can private equity owners of substance abuse centers be sued under the False Claims Act?

Yes. The DOJ increasingly names private equity firms, parent companies, and individual executive officers as defendants under the FCA if they maintained operational control, set billing quotas, or knowingly ignored non-compliant marketing practices at portfolio treatment centers.

What triggers a Civil Investigative Demand (CID) for an addiction treatment center?

A CID can be triggered by sudden spikes in billing volume, whistleblower lawsuits filed under seal by former employees, automated data-mining algorithms flagging outlier urine drug testing claims, or referrals from state licensing boards.

Is it legal for an addiction facility to waive patient copays or deductibles?

Routine, unexcused waivers of patient copays or deductibles are illegal because they induce patients to seek care they might otherwise decline. Discounts or waivers are only permissible if based on documented, individualized financial hardship evaluations that comply with federal guidelines.

Can billing for group therapy lead to False Claims Act scrutiny?

Yes. Billing individual session rates for group therapy, billing for groups that exceed allowable state-mandated participant ratios, or using unlicensed staff to conduct clinical group sessions are common triggers for FCA investigations.

How far back can the federal government audit billing records under the FCA?

The False Claims Act carries a statute of limitations that generally allows the federal government or whistleblowers to audit and bring claims for actions occurring up to 6 years prior, and in certain circumstances involving government intervention, up to 10 years.

Learn How Eisner Gorin LLP Can Help You

Navigating a federal False Claims Act investigation or responding to a Department of Justice Civil Investigative Demand (CID) requires immediate, highly experienced healthcare defense representation.

Our legal team represents substance abuse treatment centers, laboratory facilities, executive directors, and medical staff faced with federal audits, subpoenas, and whistleblower lawsuits.

Here is how our legal team protects your facility and reputation:

• Responding to CIDs and Federal Subpoenas: We manage all communications with the DOJ, HHS-OIG, and federal law enforcement, ensuring complete statutory compliance while limiting document exposure and protecting privileged corporate records.

• Conducting Internal Compliance Audits: We conduct comprehensive internal reviews of clinical documentation, coding practices, and laboratory utilization to identify billing discrepancies, correct noncompliant policies, and establish good-faith operating practices.

• Defending Against Whistleblower (Qui Tam) Suits: We investigate the claims brought by former employees or relators, working aggressively to persuade federal prosecutors not to intervene in sealed lawsuits.

• Evaluating Marketing & Referral Agreements: We review marketing contracts, sober home arrangements, and clinical referral pipelines to ensure strict compliance with the Anti-Kickback Statute (AKS) and the Eliminating Kickbacks in Recovery Act (EKRA).

• Negotiating Pre-Trial Resolutions & CIAs: When overpayments or technical violations exist, we negotiate directly with federal prosecutors to minimize financial penalties, eliminate program exclusion risks, and structure viable Corporate Integrity Agreements.

If your addiction treatment center has received a federal inquiry or you suspect potential compliance vulnerabilities, early intervention is critical. Contact our federal healthcare defense office today for a confidential consultation.

Eisner Gorin LLP is here to help you. Schedule your consultation today. Our law firm is based in Los Angeles.

Related Legal Topics

• Drug Rehab Centers Investigation
• Federal Billing and Coding Errors
• Criminal False Claims Act Exposure
• Navigate Civil Investigative Demands